
Biocytogen and BeiGene Sign Licensing Deal to Advance Antibody-Based Drug Development
Biocytogen Holdings, a global biotechnology company driving drug discovery with innovative technologies, today announced it has entered into a global licensing agreement for antibody molecules with BeiGene, a global innovator in oncology treatment. BeiGene has previously obtained the authorization to…













